How Recreational Pot Is Hurting Medical Marijuana Patients in California
Recreational marijuana is bringing in millions of tax dollars for the state of California, but there are also some downsides. Greg Zeman, associate editor at Cannabis Now, explains how the state's new laws are hurting some medical marijuana patients.
Some medical marijuana companies donate products to non-profits like the Weed For Warriors Project, which gives medical marijuana patients free pot. Due to the state's new tax regulations on weed, companies still have to pay taxes on these donations. 100 pounds of cannabis would cost roughly $50,000 in taxes.
Regulations across the country are holding American businesses back from competing with Canada, according to Zeman. He says Canadian companies are gearing up to take over global pot markets as more countries legalize recreational marijuana. California is the largest producer of cannabis, but federal regulations prevent it from selling to global markets.
Chris Versace, CIO at Tematica Research, joins to discuss earnings season trends, Flash PMI signals, Walmart’s strategy updates, and Nike’s evolving outlook.
Andrew Nusca, Editorial Director at Fortune, dives into WhatsApp’s first-ever ads rollout —and how Meta’s ad push intensifies its showdown with OpenAI.
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
